Stacking
Liraglutide is sometimes used alongside other medications, though combinations should be approached with caution and medical supervision.
With metformin: This is the most well-established combination, commonly used in type 2 diabetes management. Metformin and liraglutide have complementary mechanisms, and their combined use is supported by extensive clinical data. Additive weight loss benefits have been observed.
With insulin: Victoza is approved for use alongside basal insulin in patients with type 2 diabetes. The SCALE Insulin trial demonstrated that adding liraglutide to basal insulin improved both weight and glycemic control. Hypoglycemia risk increases when liraglutide is combined with insulin, and insulin dose reduction may be necessary.
With other GLP-1 agonists: Simultaneous use of liraglutide with semaglutide, tirzepatide, or other GLP-1 agonists is not recommended. The mechanisms overlap completely, and combining them would dramatically increase gastrointestinal side effects without meaningful additional benefit.
With growth hormone peptides: Some users in the bodybuilding and fitness community combine liraglutide with growth hormone secretagogues such as ipamorelin or sermorelin for body recomposition. This combination is experimental and off-label. Caution is warranted as both compound classes affect glucose metabolism.